Phase 1 β Early testing in a small group of people (usually 20β80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(14 sites)
United States
Collaborative Neuroscience Network - CNS, Los Alamitos, California Collaborative Neuroscience Network - CNS, Los Alamitos, California K2 Medical Research, LLC, Maitland, Florida Aqualane Clinical Research, Naples, Florida Charter Research, Orlando, Florida Progressive Medical Research, Port Orange, Florida K2 Medical Research, LLC, The Villages, Florida Charter Research, The Villages, Florida QUEST Research Institute, Farmington Hills, Michigan PPD Development, LP, Austin, Texas Evergreen Health Research, Kirkland, Washington Inland Northwest Research, Spokane, Washington Japan
Oita University Hospital, Yufu